c.ilunga
Submits third-party assay reports on material purchased directly. Based in Recife.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
99.83%
n=5
Suppliers covered
5
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041319 | ARA-290 | WWB | WWB-2511-S3009 | PeptideMeter | 2026-Q1 | 99.93 | 5.52 | 99.5 | Buyer-sourced | 0 | PASS |
| AX-2025-019791 | MK-677 (Ibutamoren mesylate) | Homopeptide | HOMO-2506-L4686 | VendorInvestigate | 2025-Q4 | 99.70 | 1.37 | 102.4 | Buyer-sourced | 0 | FAIL |
| AX-2025-019870 | Semaglutide | HJ | HJ-2507-E6156 | Medutest | 2025-Q3 | 99.83 | 5.35 | 104.3 | Buyer-sourced | 0 | PASS |
| AX-2025-020419 | Liraglutide | MKM | MKM-2508-P4928 | PeptideMeter | 2025-Q3 | 97.56 | 6.86 | 92.4 | Buyer-sourced | 0 | PASS |
| AX-2025-019367 | GHRP-2 | HYB | HYB-2501-R7240 | Janoshik | 2025-Q1 | 99.90 | 4.77 | 97.1 | Buyer-sourced | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| WWB | 1 | n<3 |
| Homopeptide | 1 | n<3 |
| HJ | 1 | n<3 |
| MKM | 1 | n<3 |
| HYB | 1 | n<3 |